GlassScriptPhysician profile
Jerry Toups
NPI 1922004381
$4,071.17
in general payments reported to CMS, 2019-2025
26 companies · $53.53 in 2025
The $53.53 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $99.35 · 2021: $278 · 2022: $313 · 2023: $104 · 2024: $2,862 · 2025: $53.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $2,800 · Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $2,800.00 |
| Food and Beverage | $220.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $2,800.00 | 2024 | |
| Smith+Nephew, INC. | $160.40 | 2019-2023 | Regranex, Collagenase Santyl |
| Abbvie INC. | $132.69 | 2021-2024 | Dalvance |
| Paratek Pharmaceuticals, INC. | $127.97 | 2020-2022 | |
| Organogenesis INC. | $125.57 | 2020-2022 | |
| Melinta Therapeutics, LLC | $91.41 | 2019 | |
| Wright Medical Technology, INC. | $88.67 | 2019 | |
| Sanara Medtech INC. | $83.45 | 2021 | |
| Averitas Pharma INC. | $83.39 | 2024-2025 | Qutenza |
| Stryker Corporation | $51.03 | 2019 | |
| Triad Life Sciences INC. | $41.50 | 2022 | |
| In2bones USA, LLC | $30.18 | 2021 | |
| Grt US Holding, INC. | $29.90 | 2021-2022 | |
| Nevro Corp. | $26.35 | 2022 | |
| Allergan, INC. | $23.51 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $22.00 | 2019 | |
| Nabriva Therapeutics, Plc | $21.14 | 2022 | |
| Ibsa Pharma INC. | $19.62 | 2023 | Tirosint, Licart |
| Mimedx Group, INC. | $18.27 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.83 | 2021 | |
| Horizon Therapeutics Plc | $16.04 | 2020 | |
| Fidia Pharma USA INC. | $15.45 | 2019-2020 | |
| Treace Medical Concepts, INC. | $12.78 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $11.68 | 2022 | |
| Tactile Systems Technology INC | $11.22 | 2019 | |
| Arteriocyte Medical Systems, INC. | $10.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Toups listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.